Clinical Trials in Brazil / NCT07830043
Starting soon Not applicable

Patient Characterization Panel to Improve Satisfaction With the Intensive Care Unit Stay (CONNECT)

NCT07830043 · tracked via the Priya Life Science Brazil tracker
Phase
Not applicable
Started
2026-10
Last updated
2026-09-21

Condition(s) studied

Critical IllnessFamily SatisfactionCritical Care, Intensive Care

Investigational drug(s) / intervention(s)

Patient-as-a-Person Characterization Panel with Staff TrainingStandard ICU Care

Patient-as-a-Person Characterization Panel with Staff Training: The Patient-as-a-Person Characterization Panel (PCPP) "Come to Know Me" is a structured 19-item instrument completed collaboratively by the multidisciplinary care team (medicine, nursing, and physical therapy) together with the patient and/or family members, and may include photographs. The panel documents the patient's identity, personal preferences, and biographical details, making this information visible to all members of the care team. It is displayed within the patient's private Intensive Care Unit (ICU) room in a location that preserves data privacy, and is completed as part of routine clinical care. Prior to each cluster's crossover, all relevant staff receive structured training on panel use; monthly retraining sessions and printed and online instructional materials are provided throughout the intervention period. Patients in the intervention arm also receive standard ICU care as practiced at each participating unit.

Standard ICU Care: During the control period, each participating ICU maintains its routine standard of care without any study-related additions. The Patient-as-a-Person Characterization Panel is not used, and no related staff training is provided. Standard care practices vary by site and are not modified by the study.

Study summary

Intensive care units (ICUs) present unique challenges to humanized, person-centered care. The severity of illness and the demands of complex technical management can displace attention from patients as individuals, making it harder to build meaningful connections with patients and their families.

This trial tests a simple, low-cost bedside intervention: a structured panel. The "Patient as a Person" panel, placed near each patient's bed. The care team, together with the patient and family, records personal information about who the patient is outside the hospital: how they prefer to be addressed, their interests, and what matters most to them. Physicians, nurses, and physical therapists receive training on how to incorporate this information into daily care interactions.

The study follows a stepped-wedge cluster randomized design across six ICUs in Brazil: four at Clinical Hospital of the University of São Paulo Medical School (São Paulo); and two at Monte Klinikum Hospital (Fortaleza). All ICUs begin with a control period of standard care. Every two months, one ICU transitions to the intervention, until all six units have adopted the panel. The total study duration is 14 months. Each ICU serves as its own control together with the comparison between ICUs for periods with and without the intervention. Questionnaire administrators are blinded to whether a given hospitalization occurred during the control or intervention phase.

Eligible participants are adult patients (≥18 years) admitted to a participating ICU for more than 48 hours, and their family members or legal representatives (≥18 years). Pregnant women, incarcerated individuals, and non-Portuguese speakers are excluded. Informed consent is obtained from family members after 48 hours of admission, and from patients once they are alert and oriented.

The primary outcome is family satisfaction with the ICU stay, assessed using the Family Satisfaction with Care in the Intensive Care Unit Questionnaire (FS-ICU 24R questionnaire), a validated intrument adapted for use in Brazil. Secondary outcomes include patient-reported quality of communication, ICU staff perceptions of the panel, and symptoms of anxiety and depression in family members at three months. Estimated enrollment is 966 patients.

The intervention involves no physical procedures. Data are coded and de-identified. Results will be published regardless of outcome.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Patient admitted to a participating ICU for more than 48 hours. * Patient aged 18 years or older. * Patient's family member or legally designated surrogate aged 18 years or older, and identifiable at the time of enrollment. * Patient and/or family member/surrogate able to speak and understand Portuguese. * Signature of the Informed Consent Form (ICF) by the family member or surrogate after 48 hours of ICU admission, and by the patient once conscious and oriented (also after 48 hours of ICU admission). Exclusion Criteria: * ICU stay of 48 hours or less. * No identifiable family member or legally designated surrogate. * Patient or family member/surrogate under 18 years of age. * Unable to speak or understand Portuguese. * Pregnant patient. * Patient deprived of liberty (incarcerated). * Refusal to sign the Informed Consent Form.

Primary outcome measure(s)

Trial sites (2)

FacilityCityRegionStatus
Monte Klinikum Hospital Fortaleza Ceará
Clinical Hospital of the University of São Paulo Medical School- Central Institute São Paulo São Paulo

More University of Sao Paulo General Hospital trials in Brazil

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07830043 on ClinicalTrials.gov ↗ ← All trials in Brazil